Elekta Ab Class B · OMXSTO:EKTA_B
Elekta Ab Class B — Q2 2024/25 Earnings Presentation
20 slides from Elekta Ab Class B's earnings presentation, Nov 27, 2024
Slide 1: Focus on profitability – Q2 report 2024/25
Focus on profitability Q2 report 2024/25 Gustaf Salford, President and CEO Tobias Hägglöv, CFO Nov 27, 2024 Restricted Information and Basic Personal Data
Slide 2: Important information
Important information This presentation includes forward-looking statements including, but not limited to, statements relating to operational and financial performance, market conditions, and other similar matters. These forward-looking statements are based on current expectations about future event
Slide 3: Business Overview
Business Overview Gustaf Salford President and CEO Restricted Information and Basic Personal Data
Slide 4: Q2 – key takeaways
Q2 – key takeaways Net sales -4% – decrease in constant exchange rates mainly due to Europe and Latin America Adj. gross margin 35.7% (36.0%) – reduced sales and changed market mix with increased volumes in Ukraine Adj. EBIT margin 9.8% (11.5%) – lower gross margin and higher amortization, cost-redu
Slide 5: Sales development by region
Sales development by region Americas – decrease of 8%1 • Decline in Latin America • Growth in the U.S. EMEA APAC – unchanged YoY1 • China’s decline was limited to 1 percent Americas 28% (30%) 37% EMEA – decrease of 5%1 (36%) Share APAC • Europe – last year major installations in of sales Spain, Ital
Slide 6: Most comprehensive product portfolio in the industry
Most comprehensive product portfolio in the industry – image guided and adaptive across 1 *Elekta Evo is not available in all markets Non-Confidential Information and Basic Personal Data
Slide 7: Elekta Evo and Elekta ONE Planning well received
Elekta Evo and Elekta ONE Planning well received Elekta Elekta ONE Evo | Planning Driving adaptive CT-guided treatments AI automated contouring and planning • CE marking and FDA submission for Evo • Positive feedback for Elekta ONE Planning − AI-driven automation in contouring • Installs ongoing – w
Slide 8: Unity: Great momentum towards a new adaptive standard of care
Unity: Great momentum towards a new adaptive standard of care! ~250 100 173 Attendees Consortium Scientific Recent highlights: members abstracts • CMM offers more precise patient treatments than ever before, treating moving targets in real time “Since adopting CMM, Lung SBRT has become the second mo
Slide 9: Financial Overview
Financial Overview Tobias Hägglöv CFO Restricted Information and Basic Personal Data
Slide 10: Financial update Q2 24/25
Financial update Q2 24/25 (SEK M) Net sales decreased by 4%1 Q2 24/25 Q2 23/24 Q1 24/25 • Solutions declined due to Europe and Latin America Net sales 4,341 4,732 3,825 • Service growth of 4%1 Solutions 2,458 2,836 1,915 Adj. gross margin of 35.7% (36.0%) Service 1,883 1,896 1,909 • Lower sales COGS
Slide 11: Q2 cash flow after continuous investments
Q2 cash flow after continuous investments (SEK M) Q2 24/25 Q2 23/24 RTM 2023/24 22/23 23/24 24/25 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 EBITDA 706 800 2,925 3,189 SEK M 1% Taxes, interest net and other -228 -251 -374 -508 -2% -4% -3% -4% -5% -5% Change in NWC -22 74 -199 -220 -6% -8% Cash flow from operatin
Slide 12: Rolling twelve months operational cash conversion
Rolling twelve months operational cash conversion SEK M 100% 3,000Operational cash flow 80% 71% 80% • SEK 2,352 M - SEK 63 M higher compared to last year 2,500 Target >70% 2,000 60% EBITDA 1,500• SEK 2,925 M – SEK 321 M lower compared to last year 40% 1,000 20% Operational cash conversion 500 2,289
Slide 13: Outlook
Outlook Gustaf Salford President and CEO Restricted Information and Basic Personal Data
Slide 14: Outlook
Outlook Sales & profitability to pick up during the second half of the year Second half 24/25 as a result of new product launches and productivity measures Net sales for Elekta are expected to grow by mid-single digit for Full year 24/25 the full year of 24/25 with an improved EBIT margin Beyond 24/
Slide 15: Summary
Summary Gustaf Salford President and CEO Restricted Information and Basic Personal Data
Slide 16: Summary
Summary • As anticipated first half 2024/25 weaker compared to last year • Product launches will drive improved profitability • Most comprehensive product portfolio in the industry Drive for an EBIT margin expansion to 14% or higher Restricted Information and Basic Personal Data
Slide 17: Upcoming events – deep dives and CMD
Upcoming events – deep dives and CMD Dec 19, 2024 Feb 21, 2025 Apr 8, 2025 May 2 - 6, 2025 May 28, 2025 Deep dive 1: R&D and product Interim report, Q3 Nov-Jan Deep dive 2: Market and ESTRO 2025 Interim report, Q4 Feb-Apr launches 2024/25 installed base etc 2024/25 Leading up to: Capital Markets Day
Slide 18: Q&A
Q&A Restricted Information and Basic Personal Data
Slide 19: We don’t just build technology, we build hope
We don’t just build technology, we build hope Restricted Information and Basic Personal Data
Slide 20: Restricted Information and Basic Personal Data
Restricted Information and Basic Personal Data